IL89150A0 - Crystalline beta-lactam solvate - Google Patents
Crystalline beta-lactam solvateInfo
- Publication number
- IL89150A0 IL89150A0 IL89150A IL8915089A IL89150A0 IL 89150 A0 IL89150 A0 IL 89150A0 IL 89150 A IL89150 A IL 89150A IL 8915089 A IL8915089 A IL 8915089A IL 89150 A0 IL89150 A0 IL 89150A0
- Authority
- IL
- Israel
- Prior art keywords
- lactam
- solvate
- crystalline beta
- beta
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15277788A | 1988-02-05 | 1988-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL89150A0 true IL89150A0 (en) | 1989-09-10 |
Family
ID=22544405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL89150A IL89150A0 (en) | 1988-02-05 | 1989-02-02 | Crystalline beta-lactam solvate |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0327364A1 (ja) |
| JP (1) | JPH021489A (ja) |
| KR (1) | KR890012960A (ja) |
| CN (1) | CN1034929A (ja) |
| AU (1) | AU615026B2 (ja) |
| DK (1) | DK49989A (ja) |
| HU (1) | HU204271B (ja) |
| IL (1) | IL89150A0 (ja) |
| NZ (1) | NZ227842A (ja) |
| PT (1) | PT89612A (ja) |
| SU (1) | SU1750429A3 (ja) |
| ZA (1) | ZA89829B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| CA2002597C (en) * | 1988-11-14 | 1999-03-23 | Thomas M. Eckrich | Solvates of b-lactam antibiotic |
| AU1234999A (en) * | 1997-11-10 | 1999-05-31 | Gist-Brocades B.V. | Crystallization of beta-lactam compounds |
| US7378408B2 (en) | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
| US7361785B2 (en) * | 2002-11-05 | 2008-04-22 | Lead Chemical Co., Ltd. | Compound protecting against ultraviolet rays |
| US8629178B2 (en) * | 2009-11-03 | 2014-01-14 | Li Liu | Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| NO155548C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
| ZA877398B (en) * | 1986-10-03 | 1989-05-30 | Lilly Co Eli | 7-((meta-substituted)phenylglycine)1-carba-1-dethiacephalosporins |
-
1989
- 1989-02-02 ZA ZA89829A patent/ZA89829B/xx unknown
- 1989-02-02 HU HU89527A patent/HU204271B/hu not_active IP Right Cessation
- 1989-02-02 EP EP89301011A patent/EP0327364A1/en not_active Withdrawn
- 1989-02-02 SU SU894613379A patent/SU1750429A3/ru active
- 1989-02-02 IL IL89150A patent/IL89150A0/xx unknown
- 1989-02-02 NZ NZ227842A patent/NZ227842A/en unknown
- 1989-02-02 KR KR1019890001185A patent/KR890012960A/ko not_active Application Discontinuation
- 1989-02-03 DK DK049989A patent/DK49989A/da not_active Application Discontinuation
- 1989-02-03 PT PT89612A patent/PT89612A/pt not_active Application Discontinuation
- 1989-02-03 AU AU29619/89A patent/AU615026B2/en not_active Expired - Fee Related
- 1989-02-03 JP JP1026523A patent/JPH021489A/ja active Pending
- 1989-02-03 CN CN89100760A patent/CN1034929A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU204271B (en) | 1991-12-30 |
| AU615026B2 (en) | 1991-09-19 |
| SU1750429A3 (ru) | 1992-07-23 |
| DK49989D0 (da) | 1989-02-03 |
| KR890012960A (ko) | 1989-09-20 |
| NZ227842A (en) | 1990-12-21 |
| CN1034929A (zh) | 1989-08-23 |
| ZA89829B (en) | 1990-10-31 |
| PT89612A (pt) | 1989-10-04 |
| JPH021489A (ja) | 1990-01-05 |
| DK49989A (da) | 1989-08-07 |
| HUT49616A (en) | 1989-10-30 |
| EP0327364A1 (en) | 1989-08-09 |
| AU2961989A (en) | 1989-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0348371A3 (en) | Drill | |
| EP0332437A3 (en) | Drill | |
| HK15497A (en) | Crystalline beta-lactam hydrate | |
| EP0420608A3 (en) | Cephalosporin derivatives | |
| EP0318704A3 (en) | 3-cyano-4-phenyl-pyrrole derivatives | |
| ZW21787A1 (en) | Cephalosporin derivatives and their crystalline derivatives | |
| EP0305322A3 (en) | Isoxazole-beta-carboline derivatives | |
| EP0297383A3 (en) | Hydroxyethyl-azolyl derivatives | |
| IL89150A0 (en) | Crystalline beta-lactam solvate | |
| IL88134A0 (en) | Substituted azacyclohexyl derivatives | |
| EP0322164A3 (en) | Ethanolamie derivatives | |
| ZA896875B (en) | Antibiotic ge 2270 | |
| IL90695A0 (en) | Substituted azacyclohexyl derivatives | |
| ZA887966B (en) | Substituted azacyclohexyl derivatives | |
| GB2200910B (en) | Thiopilocarpine derivatives | |
| IE882472L (en) | Antibiotic a80577 | |
| IE882470L (en) | Cephalosporin derivatives | |
| IE881066L (en) | Cephalosporin derivatives | |
| IE880625L (en) | Cephalosporin derivatives | |
| ZM8587A1 (en) | Antibiotic compounds | |
| GB8724649D0 (en) | Antibiotic compounds | |
| IE890351L (en) | Crystalline solvate of a 1-carbacephalosporin | |
| GR3023166T3 (en) | Novel thiazolidine derivatives | |
| IE882497L (en) | Cephalosporin derivative | |
| GB8706874D0 (en) | Cephalosporin derivatives |